Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0017160 (
gastroenteritis
)
11,398
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Salmonella
Typhimurium is an intracellular pathogen that causes
gastroenteritis
in humans. Aided by a battery of effector proteins,
S.
Typhimurium resides intracellularly in a specialized vesicle, called the
Salmonella
-containing vacuole (SCV) that utilizes the host endocytic vesicular transport pathway (VTP). Here, we probed the possible role of SUMOylation, a post-translation modification pathway, in SCV biology. Proteome analysis by complex mass-spectrometry (MS/MS) revealed a dramatically altered SUMO-proteome (SUMOylome) in
S.
Typhimurium-infected cells.
RAB7
, a component of VTP, was key among several crucial proteins identified in our study. Detailed MS/MS assays,
in vitro
SUMOylation assays and structural docking analysis revealed SUMOylation of
RAB7
(RAB7A) specifically at lysine 175. A SUMOylation-deficient
RAB7
mutant (
RAB7
K175R
) displayed longer half-life, was beneficial to SCV dynamics and functionally deficient. Collectively, the data revealed that
RAB7
SUMOylation blockade by
S.
Typhimurium ensures availability of long-lived but functionally compromised
RAB7
, which was beneficial to the pathogen. Overall, this SUMOylation-dependent switch of
RAB7
controlled by
S.
Typhimurium is an unexpected mode of VTP pathway regulation, and unveils a mechanism of broad interest well beyond
Salmonella
-host crosstalk. This article has an associated First Person interview with the first author of the paper.
...
PMID:A SUMOylation-dependent switch of RAB7 governs intracellular life and pathogenesis of
Salmonella
Typhimurium. 3051 Jan 12